ELISA Kit for Lipopolysaccharide (LPS)

LOS; Lipoglycans; Lipooligosaccharide; Lipo-Oligosaccharide; Endotoxin

Specificity

This assay has high sensitivity and excellent specificity for detection of Lipopolysaccharide (LPS).
No significant cross-reactivity or interference between Lipopolysaccharide (LPS) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Lipopolysaccharide (LPS) and the recovery rates were calculated by comparing the measured value to the expected amount of Lipopolysaccharide (LPS) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-99 94
EDTA plasma(n=5) 90-102 97
heparin plasma(n=5) 85-103 98

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lipopolysaccharide (LPS) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Lipopolysaccharide (LPS) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Lipopolysaccharide (LPS) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 97-104% 79-93% 89-102% 80-94%
EDTA plasma(n=5) 84-94% 86-94% 79-103% 95-103%
heparin plasma(n=5) 89-97% 78-92% 96-105% 84-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1 Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Reagent Diluent 1×300µL Stop Solution 1×6mL
TMB Substrate 1×9mL Instruction manual 1
Wash Buffer (30 × concentrate) 1×20mL

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Particle and Fibre Toxicology Particulate matter air pollution disrupts endothelial cell barrier via calpain-mediated tight junction protein degradation PubMed: 22931549
Journal of Neuroinflammation Hemoglobin induces inflammation after preterm intraventricular hemorrhage by methemoglobin formation PubMed: PMC3750409
Nutrition Antidiabetic effect of Lactobacillus casei CCFM0412 in high-fat-fed, streptozotocin-induced type 2 diabetic mice ScienceDirect: S0899900714001567
PLoS One. Effects of Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on Hepatic Steatosis in Zucker Rats Pubmed:24852284
PLOS ONE Immunological Activity Difference between Native Calreticulin Monomers and Oligomers Pubmed:25171171
Nutrition Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin Pubmed:25102821
Journal of Functional Foods Oral administration of Lactobacillus rhamnosus CCFM0528 improves glucose tolerance and cytokine secretion in high-fat-fed, streptozotocin-induced type 2 diabetic … Sciencedirect:S1756464614002138
summary future microbiology Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients? PubMed: 25865191
Eur J Gastroenterol Hepatol Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study PubMed: 26302024
Joural of Pharmacy & Bioallied Sciences The effects of female sexual steroids on gastric function and barrier resistance of gastrointestinal tract following traumatic brain injury PubMed: 25709342
Am J Clin Nutr Fecal menaquinone profiles of overweight adults are associated with gut microbiota composition during a gut microbiota–targeted dietary intervention PubMed26016865 :
Am J Physiol Gastrointest Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity PubMed: 26702135
International Immunopharmacology Oxymatrine attenuates CCl 4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways Pubmed:27179304
Clinics and Research in Hepatology and Gastroenterology Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability Pubmed:27160816
Nutrition Administration of probiotic mixture DM# 1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats science:S0899900716300740
Am J Physiol Gastrointest Liver Physiol Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional Cavia (Guinea pig )t-liver axis in rats Pubmed:27056726
molecular nutrition & food research Food combination based on a pre-hispanic Mexican diet decreases metabolic and cognitive abnormalities and gut microbiota dysbiosis caused by a sucrose-enriched high-fat diet in rats. pubmed:27352915
Nutrition Administration of probiotic mixture DM# 1 ameliorated 5-fluorouracil–induced intestinal mucositis and dysbiosis in rats article:S0899-9007(16)30074-0
 Biochimica et Biophysica Acta (BBA)-General Subjects Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats pubmed:28341485
Catalog No. Related products for research use of Pan-species (General) Organism species Applications (RESEARCH USE ONLY!)
CPB526Ge11 BSA Conjugated Lipopolysaccharide (LPS) Immunogen; SDS-PAGE; WB.
CPB526Ge21 OVA Conjugated Lipopolysaccharide (LPS) Immunogen; SDS-PAGE; WB.
PAB526Ge01 Polyclonal Antibody to Lipopolysaccharide (LPS) WB; IHC; ICC; IP.
LAB526Ge71 Biotin-Linked Polyclonal Antibody to Lipopolysaccharide (LPS) WB; IHC; ICC.
LAB526Ge81 FITC-Linked Polyclonal Antibody to Lipopolysaccharide (LPS) WB; IHC; ICC; IF.
MAB526Ge21 Monoclonal Antibody to Lipopolysaccharide (LPS) WB; IHC; ICC; IP.
MAB526Ge22 Monoclonal Antibody to Lipopolysaccharide (LPS) WB; IHC; ICC; IP.
LAB526Ge72 Biotin-Linked Monoclonal Antibody to Lipopolysaccharide (LPS) WB; IHC; ICC.
LAB526Ge82 FITC-Linked Monoclonal Antibody to Lipopolysaccharide (LPS) WB; IHC; ICC; IF.
SEB526Ge ELISA Kit for Lipopolysaccharide (LPS) Enzyme-linked immunosorbent assay for Antigen Detection.
MEB526Ge Mini Samples ELISA Kit for Lipopolysaccharide (LPS) Enzyme-linked immunosorbent assay for Antigen Detection.
HEB526Ge High Sensitive ELISA Kit for Lipopolysaccharide (LPS) Enzyme-linked immunosorbent assay for Antigen Detection.
CEB526Ge ELISA Kit for Lipopolysaccharide (LPS) Enzyme-linked immunosorbent assay for Antigen Detection.
IEB526Ge Instant ELISA Kit for Lipopolysaccharide (LPS) Enzyme-linked immunosorbent assay for Antigen Detection.
KSB526Ge01 ELISA Kit DIY Materials for Lipopolysaccharide (LPS) Main materials for "Do It(ELISA Kit) Yourself"
KSB526Ge11 ELISA Kit DIY Materials for Lipopolysaccharide (LPS) Main materials for "Do It (ELISA Kit) Yourself".